​

Tectonic Therapeutic (TECX) Stock Forecast, Price Target & Predictions

OverviewFinancialsChart

TECX Stock Rating

Tectonic Therapeutic stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$31.49$31.49$31.49
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 2513---4
Jan, 2513---4
Dec, 2423---5
Nov, 2423---5
Oct, 2413---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 19, 2024Raymond JamesOutperforminitialise
Sep 20, 2024Cowen & Co.BuyBuyhold
Sep 20, 2024Piper SandlerOverweightOverweighthold
Aug 22, 2024Wells FargoOverweightinitialise
Jun 26, 2024Piper SandlerOverweightinitialise
Jun 24, 2024Cowen & Co.Buyinitialise

Financial Forecast

EPS Forecast

$-15 $-11 $-7 $-3 $1 $5 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-11.59-----
Avg Forecast$1.50$-8.02$-5.04$-4.96$-6.73$-8.07
High Forecast$1.50$-4.11$-4.35$-4.96$-6.73$-8.07
Low Forecast$1.50$-12.08$-5.58$-4.96$-6.73$-8.07
Surprise %-872.67%-----

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast------
High Forecast------
Low Forecast------
Surprise %------

Net Income Forecast

$-45M $-34M $-23M $-12M $-1M $10M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-42.82M-----
Avg Forecast$5.57M$-29.79M$-18.70M$-18.42M$-24.98M$-29.97M
High Forecast$5.57M$-15.27M$-16.17M$-18.42M$-24.98M$-29.97M
Low Forecast$5.57M$-44.88M$-20.72M$-18.42M$-24.98M$-29.97M
Surprise %-868.68%-----

TECX Forecast FAQ

Is Tectonic Therapeutic stock a buy?

Tectonic Therapeutic stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Tectonic Therapeutic is a favorable investment for most analysts.

What is Tectonic Therapeutic's price target?

Tectonic Therapeutic's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $31.49.

How does Tectonic Therapeutic stock forecast compare to its benchmarks?

Tectonic Therapeutic's stock forecast shows a 0% downside.

What is the breakdown of analyst ratings for Tectonic Therapeutic over the past three months?

  • February 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Tectonic Therapeutic’s EPS forecast?

Tectonic Therapeutic's average annual EPS forecast for its fiscal year ending in December 2024 is $-8.02, marking a -30.80% decrease from the reported $-11.59 in 2023. Estimates for the following years are $-5.04 in 2025, $-4.96 in 2026, $-6.73 in 2027, and $-8.07 in 2028.

What is Tectonic Therapeutic’s revenue forecast?

Tectonic Therapeutic's average annual revenue forecast for its fiscal year ending in December 2024 is $0, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $0, followed by $0 for 2026, $0 for 2027, and $0 for 2028.

What is Tectonic Therapeutic’s net income forecast?

Tectonic Therapeutic's net income forecast for the fiscal year ending in December 2024 stands at $-29.786M, representing a -30.44% decrease from the reported $-42.823M in 2023. Projections indicate $-18.7M in 2025, $-18.418M in 2026, $-24.983M in 2027, and $-29.972M in 2028.